Month: July 2023
NEW YORK, July 5, 2023 /PRNewswire/ — The almond kernels market size is set to grow by USD 3,178.5 million between 2022 and 2027 and register a CAGR of 7.04%, according to Technavio’s latest market research report estimates. With a focus on identifying dominant industry influencers,…
DUBLIN, July 5, 2023 /PRNewswire/ — The “United States Bread Market By Type, By Ingredients, By Product Type, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2018-2031F” report has been added to ResearchAndMarkets.com’s offering. The United States bread market…
Deal combines two industry leaders in adjacent but highly complementary markets WILMINGTON, Del., July 6, 2023 /PRNewswire/ — Solenis, a leading manufacturer of specialty chemicals used in water-intensive industries, has completed its previously announced acquisition of Diversey…
NEW YORK, July 5, 2023 /PRNewswire/ — The Gross Law Firm issues the following notice to shareholders of ImmunityBio, Inc.. Shareholders who purchased shares of IBRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment….
Data Uncovers New Gene Signature to Help Understand Persistence in CAR T-cells PLEASANTON, Calif., July 5, 2023 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that its single-cell genomic technologies were used in a study…
DUBLIN, July 5, 2023 /PRNewswire/ — The “Biosimilars Market by Drug Class (Drug Class (Monoclonal Antibodies (Adalimumab, Infliximab, Rituximab, Trastuzumab), Insulin, Erythropoietin, Anticoagulants. rhGH), Indication, Region – Global Forecast to 2028” report has been added to…
Extension of BRII-179 license from VBI Vaccines to global rights bolsters Brii Bio’s position to achieve best-in-class HBV functional cure in broad patient populations Company also acquires exclusive rights to PreHevbri®, a clinically differentiated, 3-antigen prophylactic vaccine, from…
Company extends BRII-179 license to global rights and introduces preventive vaccine, PreHevbri® in Greater China and Asia Pacific markets New data from BRII-835 + PEG-IFN-α study have demonstrated that robust anti-HBs antibody responses at the end of treatment are associated with…
NEW YORK, July 5, 2023 /PRNewswire/ — Effective July 5, 2023, S&P Dow Jones Indices (“S&P DJI”) is clarifying one of the domicile eligibility criteria in the S&P U.S. Indices methodology and the Dow Jones U.S. Total Stock Market Indices methodology as detailed in the box below. This…